United States Healthcare Equipment & Supplies

Beta Bionics Inc (BBNX)

Track

Over the last 90 days, Beta Bionics Inc. has seen significant insider selling, with a net value of -$472,476. Notably, executives sold shares totaling this amount. The stock price has increased by 17.3% in the same period. The last earnings report showed an -8.6% EPS miss.
Stock chart
Ticker: BBNX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jones Christy
1 sale — total 100,000 USD
Planned sale 4 Jun 2026
Value US$1,486,739.35 | Price 181.23 | Shares 69,845
Planned sale 4 Jun 2026
Value US$1,760,714.85 | Price 101.27 | Shares 56,654
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 12.45 | Shares 1,000
Proposed sale 4 Jun 2026
Value US$100,000.00 | Price 12.31 | Shares 1,000
Sale 2 Jun 2026
Value US$100,000.00 | Price 12.61 | Shares 1,000
Sale 2 Jun 2026
Value US$100,000.00 | Price 12.61 | Shares 1,000
Sale 2 Jun 2026
Value US$100,000.00 | Price 12.61 | Shares 1,000
Sale 2 Jun 2026
Value US$100,000.00 | Price 12.61 | Shares 1,000
Sale 2 Jun 2026
Value US$100,000.00 | Price 12.61 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 12.79 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 12.79 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 12.79 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 12.79 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 12.79 | Shares 1,000
Planned sale 22 May 2026
Value US$100,000.00 | Price 11.21 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 9.95 | Shares 1,000
Planned sale 21 May 2026
Value US$100,000.00 | Price 9.95 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 10.11 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 10.11 | Shares 1,000
Planned sale 4 Mar 2026
Value US$4,084.21 | Price 11.57 | Shares 353
Proposed sale 4 Mar 2026
Value US$4,084.21 | Price 11.57 | Shares 353
Proposed sale 2 Mar 2026
Value US$13,321.28 | Price 12.52 | Shares 1,064
Proposed sale 2 Mar 2026
Value US$17,878.56 | Price 12.52 | Shares 1,428
Proposed sale 2 Mar 2026
Value US$42,367.68 | Price 12.52 | Shares 3,384
Sale 2 Mar 2026
Value US$41,831.65 | Price 12.36 | Shares 3,384
Sale 2 Mar 2026
Value US$17,652.36 | Price 12.36 | Shares 1,428
Sale 2 Mar 2026
Value US$13,152.74 | Price 12.36 | Shares 1,064
Sale 2 Mar 2026
Value US$10,309.57 | Price 12.36 | Shares 834
Sale 2 Mar 2026
Value US$12,683.00 | Price 12.36 | Shares 1,026
Planned sale 6 Jan 2026
Value US$66,221.10 | Price 30.10 | Shares 2,200
Planned sale 2 Jan 2026
Value US$18,118.14 | Price 30.20 | Shares 600
Planned sale 2 Jan 2026
Value US$212,832.00 | Price 29.56 | Shares 7,200
Planned sale 2 Jan 2026
Value US$590,680.00 | Price 29.53 | Shares 20,000
Proposed sale 2 Jan 2026
Value US$304,700.00 | Price 30.47 | Shares 10,000
Proposed sale 2 Jan 2026
Value US$590,680.04 | Price 29.53 | Shares 20,000
Proposed sale 2 Jan 2026
Value US$590,680.04 | Price 29.53 | Shares 20,000
Planned sale 4 Dec 2025
Value US$63,192.32 | Price 30.66 | Shares 2,061
Proposed sale 4 Dec 2025
Value US$63,192.28 | Price 30.66 | Shares 2,061
Sale 2 Dec 2025
Value US$25,111.53 | Price 29.34 | Shares 856
Sale 2 Dec 2025
Value US$30,069.30 | Price 29.34 | Shares 1,025
Proposed sale 2 Dec 2025
Value US$96,163.08 | Price 29.34 | Shares 3,278
Proposed sale 2 Dec 2025
Value US$41,862.33 | Price 29.34 | Shares 1,427
Proposed sale 2 Dec 2025
Value US$31,184.06 | Price 29.34 | Shares 1,063
Sale 2 Dec 2025
Value US$96,163.08 | Price 29.34 | Shares 3,278
Sale 2 Dec 2025
Value US$41,862.33 | Price 29.34 | Shares 1,427
Sale 2 Dec 2025
Value US$31,184.06 | Price 29.34 | Shares 1,063
Planned sale 1 Dec 2025
Value US$14,982.00 | Price 29.96 | Shares 500
Planned sale 1 Dec 2025
Value US$26,570.17 | Price 29.33 | Shares 906
Planned sale 1 Dec 2025
Value US$14,955.00 | Price 29.91 | Shares 500
Planned sale 1 Dec 2025
Value US$26,587.75 | Price 29.35 | Shares 906
Planned sale 31 Oct 2025
Value US$1,052.60 | Price 27.70 | Shares 38
Planned sale 31 Oct 2025
Value US$36,727.24 | Price 26.85 | Shares 1,368
Planned sale 31 Oct 2025
Value US$3,266.57 | Price 27.45 | Shares 119
Planned sale 31 Oct 2025
Value US$34,567.28 | Price 26.86 | Shares 1,287
Proposed sale 31 Oct 2025
Value US$75,305.36 | Price 26.78 | Shares 2,812
Proposed sale 31 Oct 2025
Value US$75,305.36 | Price 26.78 | Shares 2,812
Planned sale 3 Oct 2025
Value US$25,708.58 | Price 22.28 | Shares 1,154
Planned sale 3 Oct 2025
Value US$82,367.84 | Price 21.52 | Shares 3,828
Proposed sale 3 Oct 2025
Value US$108,076.24 | Price 21.69 | Shares 4,982
Planned sale 1 Oct 2025
Value US$2,108.00 | Price 21.08 | Shares 100
Planned sale 1 Oct 2025
Value US$309,697.68 | Price 20.76 | Shares 14,918
Proposed sale 1 Oct 2025
Value US$311,836.91 | Price 20.76 | Shares 15,018
Planned sale 8 Sep 2025
Value US$209,151.36 | Price 21.13 | Shares 9,900
Proposed sale 8 Sep 2025
Value US$209,152.15 | Price 21.13 | Shares 9,900
Planned sale 5 Sep 2025
Value US$234,656.95 | Price 20.56 | Shares 11,411
Proposed sale 5 Sep 2025
Value US$234,656.73 | Price 20.56 | Shares 11,411
Planned sale 5 Sep 2025
Value US$2,100.00 | Price 21.00 | Shares 100
Proposed sale 5 Sep 2025
Value US$2,100.00 | Price 21.00 | Shares 100
Planned sale 4 Sep 2025
Value US$136,180.00 | Price 19.97 | Shares 6,818
Proposed sale 4 Sep 2025
Value US$136,179.70 | Price 19.97 | Shares 6,818
Sale 2 Sep 2025
Value US$27,578.00 | Price 18.86 | Shares 1,462
Sale 2 Sep 2025
Value US$15,995.99 | Price 18.86 | Shares 848
Sale 2 Sep 2025
Value US$63,361.49 | Price 18.86 | Shares 3,359
Sale 2 Sep 2025
Value US$20,542.02 | Price 18.86 | Shares 1,089
Sale 2 Sep 2025
Value US$19,146.15 | Price 18.86 | Shares 1,015
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-04 PlS Planned sale
Jones Christy
Non-Executive Director
69,845 +7.9%
181.23
US$1,486,739 		69,845 +7.9% 181.23 US$1,486,739
2026-06-05 2026-06-04 PlS Planned sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
56,654 -3.2%
101.27
US$1,760,715 		56,654 -3.2% 101.27 US$1,760,715
2026-06-04 2026-06-04 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
60,519
376.55
US$1,800,555 		60,519 376.55 US$1,800,555
2026-06-04 2026-06-04 PrS Proposed sale
3.1
Mark Hopman

Officer

Officer
1,000
12.31
US$100,000 		1,000 12.31 US$100,000
2026-06-03 2026-06-02 S Sale
3.1
Mensinger Mike

Chief Product Officer

Officer
1,000 -2.3%
12.61
US$100,000 		1,000 -2.3% 12.61 US$100,000
2026-06-03 2026-06-02 S Sale
3.1
Russell Steven Jon

Chief Medical Officer

Officer
1,000 -2.4%
12.61
US$100,000 		1,000 -2.4% 12.61 US$100,000
2026-06-03 2026-06-02 S Sale
3.1
Saint Sean

President & CEO

Executive Director
1,000 -3.9%
12.61
US$100,000 		1,000 -3.9% 12.61 US$100,000
2026-06-03 2026-06-02 S Sale
3.1
Feider Stephen

Chief Financial Officer

Officer
1,000 -3.9%
12.61
US$100,000 		1,000 -3.9% 12.61 US$100,000
2026-06-03 2026-06-02 S Sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
1,000 -3.9%
12.61
US$100,000 		1,000 -3.9% 12.61 US$100,000
2026-06-03 2026-06-02 PrS Proposed sale
3.1
Michael R. Mensinger

Officer

Officer
1,000
12.79
US$100,000 		1,000 12.79 US$100,000
2026-06-03 2026-06-02 PrS Proposed sale
3.1
Steven Jon Russell

Officer

Officer
1,000
12.79
US$100,000 		1,000 12.79 US$100,000
2026-06-03 2026-06-02 PrS Proposed sale
3.1
Mark Hopman

Officer

Officer
1,000
12.79
US$100,000 		1,000 12.79 US$100,000
2026-06-03 2026-06-02 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
1,000
12.79
US$100,000 		1,000 12.79 US$100,000
2026-06-03 2026-06-02 PrS Proposed sale
3.1
Sean Saint

Officer; Director

Executive Director
1,000
12.79
US$100,000 		1,000 12.79 US$100,000
2026-05-26 2026-05-22 PlS Planned sale
Lezack Adam
Non-Executive Director
1,000 -3.5%
11.21
US$100,000 		1,000 -3.5% 11.21 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
Jones Christy
Non-Executive Director
1,000 -13.1%
9.95
US$100,000 		1,000 -13.1% 9.95 US$100,000
2026-05-26 2026-05-21 PlS Planned sale
Lezack Adam
Non-Executive Director
1,000 -8.0%
9.95
US$100,000 		1,000 -8.0% 9.95 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
CHRISTINA JONES

Director

Non-Executive Director
1,000
10.11
US$100,000 		1,000 10.11 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
ADAM LEZACK

Director

Non-Executive Director
1,000
10.11
US$100,000 		1,000 10.11 US$100,000
2026-03-05 2026-03-04 PlS Planned sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
353 -0.3%
11.57
US$4,084 		353 -0.3% 11.57 US$4,084
2026-03-04 2026-03-04 PrS Proposed sale
3.1
Mark Hopman

Officer

Officer
353
11.57
US$4,084 		353 11.57 US$4,084
2026-03-04 2026-03-02 PrS Proposed sale
3.1
Michael R. Mensinger

Officer

Officer
1,064
12.52
US$13,321 		1,064 12.52 US$13,321
2026-03-04 2026-03-02 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
1,428
12.52
US$17,879 		1,428 12.52 US$17,879
2026-03-04 2026-03-02 PrS Proposed sale
3.1
Sean Saint

Officer; Director

Executive Director
3,384
12.52
US$42,368 		3,384 12.52 US$42,368
2026-03-03 2026-03-02 S Sale
3.1
Saint Sean

President & CEO

Executive Director
3,384 -0.8%
12.36
US$41,832 		3,384 -0.8% 12.36 US$41,832
2026-03-03 2026-03-02 S Sale
3.1
Feider Stephen

Chief Financial Officer

Officer
1,428 -0.8%
12.36
US$17,652 		1,428 -0.8% 12.36 US$17,652
2026-03-03 2026-03-02 S Sale
3.1
Mensinger Mike

Chief Product Officer

Officer
1,064 -0.6%
12.36
US$13,153 		1,064 -0.6% 12.36 US$13,153
2026-03-03 2026-03-02 S Sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
834 -0.6%
12.36
US$10,310 		834 -0.6% 12.36 US$10,310
2026-03-03 2026-03-02 S Sale
3.1
Russell Steven Jon

Chief Medical Officer

Officer
1,026 -0.6%
12.36
US$12,683 		1,026 -0.6% 12.36 US$12,683
2026-01-07 2026-01-06 PlS Planned sale
3.1
Mensinger Mike

Chief Product Officer

Officer
2,200 -2.7%
30.10
US$66,221 		2,200 -2.7% 30.10 US$66,221
2026-01-05 2026-01-02 PlS Planned sale
3.1
Mensinger Mike

Chief Product Officer

Officer
600 -0.7%
30.20
US$18,118 		600 -0.7% 30.20 US$18,118
2026-01-05 2026-01-02 PlS Planned sale
3.1
Mensinger Mike

Chief Product Officer

Officer
7,200 -7.9%
29.56
US$212,832 		7,200 -7.9% 29.56 US$212,832
2026-01-05 2026-01-02 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
20,000 -31.9%
29.53
US$590,680 		20,000 -31.9% 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
3.1
MICHAEL MENSINGER

Officer

Officer
10,000
30.47
US$304,700 		10,000 30.47 US$304,700
2026-01-02 2026-01-02 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-01-02 2026-01-02 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
20,000
29.53
US$590,680 		20,000 29.53 US$590,680
2026-03-16 2025-12-04 PlS Planned sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
2,061 -1.5%
30.66
US$63,192 		2,061 -1.5% 30.66 US$63,192
2025-12-04 2025-12-04 PrS Proposed sale
3.1
Mark Hopman

Officer

Officer
2,061
30.66
US$63,192 		2,061 30.66 US$63,192
2026-03-16 2025-12-02 S Sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
856 -0.6%
29.34
US$25,112 		856 -0.6% 29.34 US$25,112
2026-03-16 2025-12-02 S Sale
3.1
Russell Steven Jon

Chief Medical Officer

Officer
1,025 -0.6%
29.34
US$30,069 		1,025 -0.6% 29.34 US$30,069
2025-12-04 2025-12-02 PrS Proposed sale
3.1
Sean Saint

Officer; Director

Executive Director
3,278
29.34
US$96,163 		3,278 29.34 US$96,163
2025-12-04 2025-12-02 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
1,427
29.34
US$41,862 		1,427 29.34 US$41,862
2025-12-04 2025-12-02 PrS Proposed sale
3.1
Michael R. Mensinger

Officer

Officer
1,063
29.34
US$31,184 		1,063 29.34 US$31,184
2025-12-04 2025-12-02 S Sale
3.1
Saint Sean

President & CEO

Executive Director
3,278 -3.2%
29.34
US$96,163 		3,278 -3.2% 29.34 US$96,163
2025-12-04 2025-12-02 S Sale
3.1
Feider Stephen

Chief Financial Officer

Officer
1,427 -3.2%
29.34
US$41,862 		1,427 -3.2% 29.34 US$41,862
2025-12-04 2025-12-02 S Sale
3.1
Mensinger Mike

Chief Product Officer

Officer
1,063 -1.2%
29.34
US$31,184 		1,063 -1.2% 29.34 US$31,184
2025-12-02 2025-12-01 PlS Planned sale
Palasis Maria
Non-Executive Director
500 -5.6%
29.96
US$14,982 		500 -5.6% 29.96 US$14,982
2025-12-02 2025-12-01 PlS Planned sale
Palasis Maria
Non-Executive Director
906 -9.2%
29.33
US$26,570 		906 -9.2% 29.33 US$26,570
2025-12-02 2025-12-01 PlS Planned sale
Lezack Adam
Non-Executive Director
500 -5.6%
29.91
US$14,955 		500 -5.6% 29.91 US$14,955
2025-12-02 2025-12-01 PlS Planned sale
Lezack Adam
Non-Executive Director
906 -9.2%
29.35
US$26,588 		906 -9.2% 29.35 US$26,588
2025-11-05 2025-10-31 PlS Planned sale
Lezack Adam
Non-Executive Director
38 -0.4%
27.70
US$1,053 		38 -0.4% 27.70 US$1,053
2025-11-05 2025-10-31 PlS Planned sale
Lezack Adam
Non-Executive Director
1,368 -12.2%
26.85
US$36,727 		1,368 -12.2% 26.85 US$36,727
2025-11-05 2025-10-31 PlS Planned sale
Palasis Maria
Non-Executive Director
119 -1.2%
27.45
US$3,267 		119 -1.2% 27.45 US$3,267
2025-11-05 2025-10-31 PlS Planned sale
Palasis Maria
Non-Executive Director
1,287 -11.4%
26.86
US$34,567 		1,287 -11.4% 26.86 US$34,567
2025-10-31 2025-10-31 PrS Proposed sale
ADAM LEZACK

Director

Non-Executive Director
2,812
26.78
US$75,305 		2,812 26.78 US$75,305
2025-10-31 2025-10-31 PrS Proposed sale
MARIA PALASIS

Director

Non-Executive Director
2,812
26.78
US$75,305 		2,812 26.78 US$75,305
2025-10-07 2025-10-03 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
1,154 -2.6%
22.28
US$25,709 		1,154 -2.6% 22.28 US$25,709
2025-10-07 2025-10-03 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
3,828 -7.8%
21.52
US$82,368 		3,828 -7.8% 21.52 US$82,368
2025-10-03 2025-10-03 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
4,982
21.69
US$108,076 		4,982 21.69 US$108,076
2025-10-03 2025-10-01 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
100 -0.2%
21.08
US$2,108 		100 -0.2% 21.08 US$2,108
2025-10-03 2025-10-01 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
14,918 -25.3%
20.76
US$309,698 		14,918 -25.3% 20.76 US$309,698
2025-10-01 2025-10-01 PrS Proposed sale
3.1
Stephen Feider

Officer

Officer
15,018
20.76
US$311,837 		15,018 20.76 US$311,837
2025-09-09 2025-09-08 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
9,900 -18.4%
21.13
US$209,151 		9,900 -18.4% 21.13 US$209,151
2025-09-08 2025-09-08 PrS Proposed sale
3.1
Feider Stephen

Officer

Officer
9,900
21.13
US$209,152 		9,900 21.13 US$209,152
2025-09-08 2025-09-05 PlS Planned sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
11,411 -26.8%
20.56
US$234,657 		11,411 -26.8% 20.56 US$234,657
2025-09-08 2025-09-05 PlS Planned sale
3.1
Feider Stephen

Chief Financial Officer

Officer
100 -0.2%
21.00
US$2,100 		100 -0.2% 21.00 US$2,100
2025-09-05 2025-09-05 PrS Proposed sale
3.1
Hopman Mark

Officer

Officer
11,411
20.56
US$234,657 		11,411 20.56 US$234,657
2025-09-05 2025-09-05 PrS Proposed sale
3.1
Feider Stephen

Officer

Officer
100
21.00
US$2,100 		100 21.00 US$2,100
2025-09-08 2025-09-04 PlS Planned sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
6,818 -17.9%
19.97
US$136,180 		6,818 -17.9% 19.97 US$136,180
2025-09-04 2025-09-04 PrS Proposed sale
3.1
Hopman Mark

Officer

Officer
6,818
19.97
US$136,180 		6,818 19.97 US$136,180
2025-09-04 2025-09-02 S Sale
3.1
Feider Stephen

Chief Financial Officer

Officer
1,462 -3.2%
18.86
US$27,578 		1,462 -3.2% 18.86 US$27,578
2025-09-04 2025-09-02 S Sale
3.1
Hopman Mark

Chief Commercial Officer

Officer
848 -2.5%
18.86
US$15,996 		848 -2.5% 18.86 US$15,996
2025-09-04 2025-09-02 S Sale
3.1
Saint Sean

President & CEO

Executive Director
3,359 -3.2%
18.86
US$63,361 		3,359 -3.2% 18.86 US$63,361
2025-09-04 2025-09-02 S Sale
3.1
Mensinger Mike

Chief Product Officer

Officer
1,089 -1.2%
18.86
US$20,542 		1,089 -1.2% 18.86 US$20,542
2025-09-04 2025-09-02 S Sale
3.1
Russell Steven Jon

Chief Medical Officer

Officer
1,015 -1.4%
18.86
US$19,146 		1,015 -1.4% 18.86 US$19,146
Explore more

More insider trading research around Beta Bionics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America